Outpatient vs Hospital Evaluation for Chest Pain
(CARE-CP Trial)
Trial Summary
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. Please consult with the trial coordinators for more details.
What data supports the effectiveness of the treatment Hospitalization Evaluation, Inpatient Evaluation, Hospital Admission, Outpatient Evaluation, Cardiovascular Ambulatory Rapid Evaluation, CARE-CP, Outpatient Management for chest pain?
Research on same-day discharge after percutaneous coronary intervention (PCI) for stable coronary artery disease suggests that outpatient management can be effective and safe, potentially reducing hospital costs without compromising patient safety. This indicates that outpatient evaluation and management for chest pain might also be effective in certain cases, similar to the approach used in PCI.12345
Is it safe to evaluate chest pain in an outpatient setting compared to a hospital setting?
How does the treatment for chest pain in the 'Outpatient vs Hospital Evaluation for Chest Pain' trial differ from other treatments?
This treatment is unique because it explores managing chest pain patients with intermediate risk scores as outpatients, potentially reducing the need for hospital admission. This approach could save resources and costs while still providing timely care through rapid access chest pain clinics.911121314
What is the purpose of this trial?
The goal of this study is to determine if rapid outpatient evaluation vs hospitalization management is the best strategy (based on patient-centered measures and safe, equitable, and efficient resource use) for evaluating patients with acute chest pain who are at moderate risk for acute coronary syndrome (ACS). Patients will be randomized in the Emergency Department to either an outpatient evaluation (CARE-CP) or hospitalization evaluation for their symptoms.
Research Team
Simon Mahler, MD, MS
Principal Investigator
Wake Forest University Health Sciences
Eligibility Criteria
This trial is for adults over 21 with chest pain or symptoms suggesting a moderate risk of acute coronary syndrome, but without severe heart conditions like prior heart attacks or major artery blockages. They must have normal troponin levels and no other serious health issues that require hospitalization.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Randomization and Initial Evaluation
Participants are randomized to either outpatient evaluation (CARE-CP) or hospitalization evaluation for their symptoms.
Follow-up
Participants are monitored for safety and effectiveness after initial evaluation, with focus on medical management for cardiovascular risk factors.
Long-term Follow-up
Participants are monitored for cardiovascular rehospitalizations and other outcomes at 1 year post-randomization.
Treatment Details
Interventions
- Hospitalization Evaluation
- Outpatient Evaluation
Hospitalization Evaluation is already approved in United States, European Union, Canada for the following indications:
- Acute Chest Pain
- Suspected Acute Coronary Syndrome (ACS)
- Acute Chest Pain
- Suspected ACS
- Cardiovascular Emergencies
- Acute Chest Pain
- Suspected ACS
- Cardiac Conditions Requiring Monitoring
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor
Agency for Healthcare Research and Quality (AHRQ)
Collaborator